NCT01807871 arm group 267d6ab23ad2d1c46b7e2189f570f7c1 [clinicaltrials_resource:NCT01807871/arm-group/267d6ab23ad2d1c46b7e2189f570f7c1]
arm group [clinicaltrials_vocabulary:arm-group]
NCT01807871 arm group 267d6ab23ad2d1c46b7e2189f570f7c1 [clinicaltrials_resource:NCT01807871/arm-group/267d6ab23ad2d1c46b7e2189f570f7c1]
Bio2RDF identifier
NCT01807871/arm-group/267d6ab23ad2d1c46b7e2189f570f7c1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 7d6ab23ad2d1c46b7e2189f570f7c1
description [clinicaltrials_vocabulary:description]
Participants will discontinue ...... d use of the nicotine patches.
identifier
clinicaltrials_resource:NCT01807871/arm-group/267d6ab23ad2d1c46b7e2189f570f7c1
title
NCT01807871 arm group 267d6ab23ad2d1c46b7e2189f570f7c1
@en
type
label
NCT01807871 arm group 267d6ab2 ...... d6ab23ad2d1c46b7e2189f570f7c1]
@en